Validation and Improvement Opportunities of the Revised International Staging System for Multiple Myeloma: An Analysis on Mature Data from European Clinical Trials within the Harmony Big Data Platform

被引：0

作者：

D'Agostino, Mattia ^{[1
]}

Waage, Anders ^{[2
]}

Lahuerta, Juan-Jose ^{[3
]}

Bertsch, Uta ^{[4
]}

Zamagni, Elena ^{[1
]}

Bullinger, Lars ^{[4
]}

Larocca, Alessandra ^{[1
]}

Mateos, Maria-Victoria ^{[3
]}

Van de Donk, Niels W. C. J. ^{[5
]}

Salwender, Hans Juergen ^{[4
]}

Blade, Joan ^{[3
]}

Van der Holt, Bronno ^{[5
]}

Tacchetti, Paola ^{[1
]}

Ciccone, Giovannino ^{[1
]}

Zweegman, Sonja ^{[5
]}

Goldschmidt, Hartmut ^{[4
]}

Cavo, Michele ^{[1
]}

San-Miguel, Jesus ^{[3
]}

Sonneveld, Pieter ^{[5
]}

Boccadoro, Mario ^{[1
]}

Hernandez-Rivas, Jesus Maria ^{[3
]}

机构：

[1] HARMONY, European Network, Florence, Italy

[2] HARMONY, European Network, Oslo, Norway

[3] HARMONY, European Network, Barcelona, Spain

[4] HARMONY, European Network, Berlin, Germany

[5] HARMONY, European Network, The Hague, Netherlands

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124321

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1773

引用

页数：5

共 23 条

[1] A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 Patients Collected By European Myeloma Network within Harmony Big Data Platform
D'Agostino, Mattia
Lahuerta, Juan-Jose
Wester, Ruth
Waage, Anders
Bertsch, Uta
Zamagni, Elena
Mateos, Maria-Victoria
Larocca, Alessandra
Dall'Olio, Daniele
van de Donk, Niels W. C. J.
Cairns, David
Rocchi, Serena
Salwender, Hans
Creixenti, Joan Blade
van der Holt, Bronno
Gastone, Castellani
Ciccone, Giovannino
Capra, Andrea
Durig, Jan
Bringhen, Sara
Zweegman, Sonja
Cavo, Michele
Goldschmidt, Hartmut
Cook, Gordon
Hernandez-Rivas, Jesus Maria
San-Miguel, Jesus F.
Boccadoro, Mario
Sonneveld, Pieter
BLOOD, 2020, 136
[2] R2-ISS, A NEW RISK STRATIFICATION MODEL IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): ANALYSIS OF 7077 PATIENT DATA BY THE EUROPEAN MYELOMA NETWORK (EMN) WITHIN HARMONY BIG DATA PLATFORM PROJECT
D'Agostino, M.
Lahuerta, J. J.
Wester, R.
Waage, A.
Bertsch, U.
Zamagni, E.
Mateos, M. V.
Larocca, A.
Dall'Olio, D.
Van de Donk, N. W. C. J.
Cairns, D.
Rocchi, S.
Salwender, H.
Blade, J.
van der Holt, B.
Castellani, G.
Ciccone, G.
Capra, A.
Durig, J.
Bringhen, S.
Zweegman, S.
Cavo, M.
Goldschmidt, H.
Cook, G.
Rivas, J. M. Hernandez
San-Miguel, J.
Boccadoro, M.
Sonneveld, P.
HAEMATOLOGICA, 2021, 106 (10) : 12 - 12
[3] Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study
Goldsmith, Scott R.
Fiala, Mark A.
Dukeman, James
Ghobadi, Armin
Stockerl-Goldstein, Keith
Schroeder, Mark A.
Tomasson, Michael
Wildes, Tanya M.
Vij, Ravi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 285 - 289
[4] Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
D'Agostino, Mattia
Cairns, David A.
Lahuerta, Juan Jose
Wester, Ruth
Bertsch, Uta
Waage, Anders
Zamagni, Elena
Mateos, Maria-Victoria
Dall'Olio, Daniele
van de Donk, Niels W. C. J.
Jackson, Graham
Rocchi, Serena
Salwender, Hans
Creixenti, Joan Blade
van der Holt, Bronno
Castellani, Gastone
Bonello, Francesca
Capra, Andrea
Mai, Elias K.
Durig, Jan
Gay, Francesca
Zweegman, Sonja
Cavo, Michele
Kaiser, Martin F.
Goldschmidt, Hartmut
Hernandez Rivas, Jesus Maria
Larocca, Alessandra
Cook, Gordon
San-Miguel, Jesus F.
Boccadoro, Mario
Sonneveld, Pieter
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3406 - +
[5] VALIDATION OF REVISED INTERNATIONAL STAGING SYSTEM (R-ISS) IN THE ERA OF NOVEL AGENTS: REAL-WORLD DATA ON 481 MYELOMA PATIENTS FROM A GREEK MYELOMA CENTER
Giannopoulou, E.
Terpos, E.
Konstantinidou, P.
Verrou, E.
Papadaki, S.
Palaska, V.
Gerofotis, A.
Karampatzakis, N.
Kokoviadou, K.
Markala, D.
Gagkos, E.
Batsis, I.
Anagnostopoulos, A.
Katodritou, E.
HAEMATOLOGICA, 2016, 101 : 782 - 782
[6] Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma
Paiva, Bruno
Zherniakova, Anastasiia
Nunez-Cordoba, Jorge M.
Rodriguez-Otero, Paula
Shi, Qian
Munshi, Nikhil C.
Durie, Brian G. M.
San-Miguel, Jesus
BLOOD ADVANCES, 2024, 8 (01) : 219 - 223
[7] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple Myeloma: a Meta-analysis of Data from Clinical Trials
Chen, Runzhe
Chen, Baoan
Zhang, Xiaoping
Gao, Chong
DISCOVERY MEDICINE, 2016, 22 (121) : 189 - 199
[8] Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project (vol 40, pg 3406, 2022)
D'Agostino
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (34) : 4032 - 4032
[9] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple myeloma: a Meta Analysis of Individual Patient Data from Clinical Trials
Chen, Runzhe
Chen, Baoan
Ge, Zheng
BLOOD, 2016, 128 (22)
[10] Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
Radocha, Jakub
Maisnar, Vladimir
Pour, Ludek
Spicka, Ivan
Minarik, Jiri
Szeligova, Lenka
Pavlicek, Petr
Jungova, Alexandra
Krejci, Marta
Pika, Tomas
Straub, Jan
Brozova, Lucie
Stejskal, Lukas
Heindorfer, Adriana
Jindra, Pavel
Kessler, Petr
Mikula, Peter
Sykora, Michal
Wrobel, Marek
Jarkovsky, Jiri
Hajek, Roman
CANCER MEDICINE, 2018, 7 (08): : 4132 - 4145

← 1 2 3 →